오름테라퓨틱

475830KOSDAQView the 제약 sectorTheme Bio & healthcare

16,070KRWMarket close of 10/27 (Tue)

Down -0.25%-40KRWMarket close of 10/27 (Tue)

Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)16,360KRWUp +1.80%

Preliminary · replaced once official KRX data for the same date is published

Open
16,300
High
16,850
Low
15,800
Day range
Day range low 15,800 high 16,850, open 16,300, close 16,070, previous close 16,110
Volume
13×10K shares
2.2B KRW 0.29× the 20-session average

Market close of 10/27 (Tue)

Where it sits in the 1-year range

1-year close range 16,020 to 143,700 won, 0% up from the low

0% of the way up from the lowest close in 1 year (252 sessions) · -88.8% from the high

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27

Points to check

  • Earningsto check-65.6B KRWOperating income over the last four quarters -65.6B KRW (loss)Operating income, 6 quarters
  • Foreign & institutionalto check-1.4B KRW5 sessions: foreign -0.9B KRW · institutional -0.5B KRW
    Last 5 sessions: foreigners -900.00 million KRW · institutions -500.00 million KRW
  • Recent filingsnot verifiedCould not read filing data, so not verified

The other 2 are within the usual range

  • Daily move-0.25%usual range
  • Trading value0.3×usual range
See the full check report

Same sector · 제약

Down -2.22%

· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +0.6%Down -5.37%124.5B KRW
셀트리온Close over the last 20 sessions +6.3%Down -0.74%82.4B KRW
지투지바이오Close over the last 20 sessions +22.2%Down -13.38%46.9B KRW
한미약품Close over the last 20 sessions -32.6%Down -0.57%25.5B KRW
에스티팜Close over the last 20 sessions -11.9%Down -9.15%21.4B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 19 days
  • Next data 10/29 (Thu) after 08:50

Related news

All news
Loading

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.